Back to results
US 9,517,254 B2Granted
Treatment regimens
AssigneeS1 Biopharma, Inc.
InventorsNicolas G. Sitchon, Robert E. Pyke, John F. Kaufmann
Life of this patent
Estimating the term…
Abstract
The invention further relates to compounds, pharmaceutical compositions and methods for treating all disorders of human sexual function including hypoactive sexual desire disorder (HSDD) in a subject.
Claims20
A composition comprising a 5-HT2A antagonist, a norepinephrine-dopamine reuptake inhibitor, an oxytocin receptor (OXTR) agonist, and a pharmaceutically acceptable carrier.
A method of making a composition comprising combining a 5-HT1A agonist, a 5-HT2A antagonist, a norepinephrine-dopamine reuptake inhibitor, an oxytocin receptor (OXTR) agonist, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.